Wenyan Gong

Dr. Wenyan Gong

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
XLXiaokun Lou
Xiaokun Lou
YZYuanyuan Zhang
Yuanyuan Zhang
JGJunfeng Guo
Junfeng Guo
LGLina Gao
Lina Gao
YDYingying Ding
Yingying Ding
QJQibin Jiao
Qibin Jiao

26 February 2024 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
YSYiyi Shou
Yiyi Shou
XLXingyu Li
Xingyu Li
QFQuan Fang
Quan Fang
AXAqiong Xie
Aqiong Xie
YZYinghong Zhang
Yinghong Zhang
DYDong Yang
Dong Yang
Diabetic cardiomyopathy (DCM) is a condition characterized by myocardial dysfunction that occurs in individuals with diabetes, in the absence of coronary artery disease, valve disease, and other conventional cardiovascular risk factors such as hypertension and dyslipidemia. It is considered a significant and consequential complication of diabetes in the field of cardiovascular medicine. The primary pathological manifestations include myocardial hypertrophy, myocardial fibrosis, and impaired ventricular function, which can lead to widespread myocardial necrosis. Ultimately, this can progress to the development of heart failure, arrhythmias, and cardiogenic shock, with severe cases even resulting in sudden cardiac death. Despite several decades of both fundamental and clinical research conducted globally, there are currently no specific targeted therapies available for DCM in clinical practice, and the incidence and mortality rates of heart failure remain persistently high. Thus, this article provides an overview of the current treatment modalities and novel techniques pertaining to DCM, aiming to offer valuable insights and support to researchers dedicated to investigating this complex condition.

5 October 2023 in The FASEB Journal
Verified
Journal Article
Closed access
HLhui luo
hui luo
QJQi‐Bin Jiao
Qi‐Bin Jiao
CSChuan‐Bin Shen
Chuan‐Bin Shen
WGWenyan Gong
Wenyan Gong
JYJing‐Hua Yuan
Jing‐Hua Yuan
XZXing‐Wei Zhang
Xing‐Wei Zhang

24 March 2023 in Clinical Science
Verified
Journal Article
Open access
PDF file
WGWenyan Gong
Wenyan Gong
QJQibin Jiao
Qibin Jiao
JYJinghua Yuan
Jinghua Yuan
HLHui Luo
Hui Luo
YLYingying Liu
Yingying Liu
XZXingwei Zhang
Xingwei Zhang
Previous studies of the Caveolin 1 (Cav1) protein and caveolae, which are lipid raft structures found on the plasma membranes of certain cells, are associated with fat metabolism disorders, inflammation, diabetes and cardiovascular disease. However, there have been no reports linking Cav1 to diabetic cardiomyopathy (DCM). In this study, we established a relationship between Cav1 and the development of DCM. We found that compared with Cav1+/+ mice, Cav1-/- diabetic mice exhibited more severe cardiac injury, increased activation of NF-κB signaling, and upregulation of downstream genes, including hypertrophic factors and inflammatory fibrosis factors in heart tissues. Additionally, in vitro results showed that knocking down Cav1 further activated HG-induced NF-κB signaling, increased the expression of downstream target genes, and decreased the expression of inhibitor α of NF-κB (iκBα), all of which have been linked to DCM pathogenesis. In contrast, Cav1 overexpression resulted in the opposite effects. Our study suggests that Cav1 knockdown promotes cardiac injury in DCM by activating the NF-κB signaling pathway, and targeting Cav1 may lead to the development of novel treatments for DCM.

5 November 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
YYYan Yang
Yan Yang
HXHaiming Xiao
Haiming Xiao
ZLZeyuan Lin
Zeyuan Lin
RCRui Chen
Rui Chen
SLShanshan Li
Shanshan Li
HHHeqing Huang
Heqing Huang

15 September 2024 in Phytomedicine
Verified
Journal Article
Closed access
WGWenyan Gong
Wenyan Gong
NZNingzhi Zhang
Ningzhi Zhang
XSXiaohong Sun
Xiaohong Sun
YZYuanyuan Zhang
Yuanyuan Zhang
YWYu Wang
Yu Wang
QJQibin Jiao
Qibin Jiao